Continuous processes for the production of pharmaceutical intermediates and active pharmaceutical ingredients

被引:0
|
作者
LaPorte, Thomas L. [1 ]
Wang, Chenchi [1 ]
机构
[1] Bristol Myers Squibb Co, New Brunswick, NJ 08903 USA
关键词
continuous flow reactor; microreactor; numbering-up; scale-up; static mixer;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Continuous processing can be applied to the production of pharmaceutical intermediates and active pharmaceutical ingredients. Relatively small, well-designed continuous reactors offer enhanced heat and mass transfer rates, shorter inventories of hazardous materials and precise control of reaction and quench times compared with batch processing. These factors have a significant impact on the safety, quality and economics of a process. Continuous processing, a mainstay of the chemical industry, remains a novelty within the pharmaceutical industry; however, there has been renewed interest in the application of continuous processing to organic synthesis in the pharmaceutical industry in recent years, and this review discusses the opportunities for reaction engineering of low-molecular-weight compounds.
引用
收藏
页码:738 / 745
页数:8
相关论文
共 50 条
  • [1] Handling of highly active pharmaceutical ingredients and intermediates in the pharmaceutical industry
    Miedinger, David
    [J]. SAFETY AND HEALTH AT WORK, 2022, 13 : S39 - S39
  • [2] Modeling a seeded continuous crystallizer for the production of active pharmaceutical ingredients
    Besenhard, M. O.
    Hohl, R.
    Hodzic, A.
    Eder, R. J. P.
    Khinast, J. G.
    [J]. CRYSTAL RESEARCH AND TECHNOLOGY, 2014, 49 (2-3) : 92 - 108
  • [3] Continuous flow asymmetric synthesis of chiral active pharmaceutical ingredients and their advanced intermediates
    Otvos, Sandor B.
    Kappe, C. Oliver
    [J]. GREEN CHEMISTRY, 2021, 23 (17) : 6117 - 6138
  • [4] Heterogeneous nucleation of active pharmaceutical ingredients on polymers: Applications in continuous pharmaceutical manufacturing
    Tan, Li
    Myerson, Allan
    Trout, Bernhardt
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [5] Synthetic Development of Key Intermediates and Active Pharmaceutical Ingredients (APIs)
    Laha, Joydev K.
    Zhou, Jianrong Steve
    [J]. SYNTHESIS-STUTTGART, 2024, 56 (04):
  • [6] Automated Sample Preparation for ICP Analysis of Active Pharmaceutical Ingredients and Intermediates
    Sims, Jonathan
    Smith, Andrew
    Patel, Dharmista
    Batchelor, Richard
    Carreira, Judith
    [J]. JALA, 2011, 16 (05): : 377 - 380
  • [7] Understanding flow chemistry for the production of active pharmaceutical ingredients
    Burange, Anand S.
    Osman, Sameh M.
    Luque, Rafael
    [J]. ISCIENCE, 2022, 25 (03)
  • [8] An Approach to the Commercial Production of Highly Active Pharmaceutical Ingredients
    Beyeler, Andreas
    Wilhelm, Roland
    Brodbeck, Bernd
    [J]. CHIMIA, 2016, 70 (09) : 596 - 603
  • [9] A systematic methodology for the design of continuous active pharmaceutical ingredient production processes
    Cervera, Albert E.
    Gani, Rafiqul
    Kiil, Soren
    Skovby, Tommy
    Gernaey, Krist V.
    [J]. 21ST EUROPEAN SYMPOSIUM ON COMPUTER AIDED PROCESS ENGINEERING, 2011, 29 : 271 - 275
  • [10] Continuous Manufacturing of Active Pharmaceutical Ingredients: Current Trends and Perspectives
    Hyer, Andres
    Gregory, Daniel
    Kay, Kaitlin
    Le, Quang
    Turnage, Justin
    Gupton, Frank
    Ferri, James K.
    [J]. ADVANCED SYNTHESIS & CATALYSIS, 2024, 366 (03) : 357 - 389